BIBR 1048

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Venous Thromboembolism

Phase 2

BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

CompletedNCT01225822

Boehringer IngelheimVenous Thromboembolism

Start: 2002-11-30Updated: 2014-05-19

BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery

CompletedNCT02170701

Boehringer IngelheimVenous Thromboembolism

Start: 2000-10-31Updated: 2018-08-31

Related Papers

Dabigatran unpublished studies = 12 out of 22 ClinicalTrials.gov records with results completed before January 2012

Figshare2014-01-01